Breaking the Silence: Navigating Advanced Endometrial Cancer

Medscape

Endometrial cancer is one of the most common gynecological malignancies and the fifth most common cancer type in women. Diagnosis and treatment options have evolved during the past 10 years with the introduction of biomarkers that can inform treatment.

6 episodi

Living With Endometrial Cancer: Understanding Patient Perspectives to Improve Overall Care
15/2/2024
12:33
Join for a discussion on the impact of endometrial cancer (EC) on patients' quality of life (QoL). Credit available for this activity expires: 2/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000137?ecd=bdc_podcast_libsyn_mscpedu
More Than High and Low Risk: How We Have Learned That Endometrial Cancer Is Not a Single Malignancy
22/12/2023
15:05
The experts discuss subtypes and molecular classification of endometrial cancer (EC). Credit available for this activity expires: 12/22/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999291?ecd=bdc_podcast_libsyn_mscpedu
Non perdere nemmeno un episodio di “Breaking the Silence: Navigating Advanced Endometrial Cancer”. Iscriviti all'app gratuita GetPodcast.
Beyond Primary Treatment: How Else Can We Benefit Our Patients Through a Holistic Approach to Care?
20/12/2023
14:17
The experts discuss how to support patients during treatment for endometrial cancer (EC). Credit available for this activity expires: 12/20/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999343?ecd=bdc_podcast_libsyn_mscpedu
The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?
20/12/2023
14:30
The experts discuss recent clinical trial data in endometrial cancer (EC). Credit available for this activity expires: 12/20/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999338?ecd=bdc_podcast_libsyn_mscpedu
To Combine or Not to Combine Chemotherapy and Immunotherapy, Is That the Question in Endometrial Cancer?
19/12/2023
15:04
Join the experts for a discussion chemotherapy and immunotherapy in treating metastatic endometrial cancer (EC). Credit available for this activity expires: 12/19/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999289?ecd=bdc_podcast_libsyn_mscpedu
The Story So Far: The Long and Short of Clinical Development in Endometrial Cancer
11/12/2023
16:34
Dr Banerjee presents the history of the last 10 years in endometrial cancer (EC). Credit available for this activity expires: 12/8/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999026?ecd=bdc_podcast_libsyn_mscpedu

Accedi a tutto il mondo dei podcast con l’app gratuita GetPodcast.

Iscriviti ai tuoi podcast preferiti, ascolta gli episodi offline e ricevi fantastici consigli.

Un'azienda di

Breaking the Silence: Navigating Advanced Endometrial Cancer

Medscape

6 episodi

Living With Endometrial Cancer: Understanding Patient Perspectives to Improve Overall Care

More Than High and Low Risk: How We Have Learned That Endometrial Cancer Is Not a Single Malignancy

Beyond Primary Treatment: How Else Can We Benefit Our Patients Through a Holistic Approach to Care?

The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?

To Combine or Not to Combine Chemotherapy and Immunotherapy, Is That the Question in Endometrial Cancer?

The Story So Far: The Long and Short of Clinical Development in Endometrial Cancer